These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 25003190)
1. CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses. Yamamoto M; Onogi H; Kii I; Yoshida S; Iida K; Sakai H; Abe M; Tsubota T; Ito N; Hosoya T; Hagiwara M J Clin Invest; 2014 Aug; 124(8):3479-88. PubMed ID: 25003190 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of HIV-1 replication by the CDK9 inhibitor FIT-039. Okamoto M; Hidaka A; Toyama M; Hosoya T; Yamamoto M; Hagiwara M; Baba M Antiviral Res; 2015 Nov; 123():1-4. PubMed ID: 26304705 [TBL] [Abstract][Full Text] [Related]
3. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor. Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV mBio; 2019 May; 10(3):. PubMed ID: 31088925 [TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG. Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation. Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132 [TBL] [Abstract][Full Text] [Related]
6. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication. Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051 [TBL] [Abstract][Full Text] [Related]
7. Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication. Tavis JE; Wang H; Tollefson AE; Ying B; Korom M; Cheng X; Cao F; Davis KL; Wold WS; Morrison LA Antimicrob Agents Chemother; 2014 Dec; 58(12):7451-61. PubMed ID: 25267681 [TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo. Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice. Yoshida Y; Yamamura J; Sato H; Koyasu M; Obara Y; Sekiguchi H; Kawana T; Shiraki K J Dermatol Sci; 1996 Dec; 13(3):237-41. PubMed ID: 9023706 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcription. Ou M; Sandri-Goldin RM PLoS One; 2013; 8(10):e79007. PubMed ID: 24205359 [TBL] [Abstract][Full Text] [Related]
12. [Antiviral effect of novel purine conjugate LAS-131 against Herpes simplex virus type 1 (Herpesviridae: Alphaherpesvirinae: Simplexvirus: Human alphaherpesvirus 1) in vitro]. Andronova VL; Galegov GA; Musiyak VV; Vozdvizhenskaya OA; Levit GL; Krasnov VP Vopr Virusol; 2021 Jan; 65(6):373-380. PubMed ID: 33533233 [TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs. Marcelletti JF Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721 [TBL] [Abstract][Full Text] [Related]
14. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection. Bridges CG; Ahmed SP; Sunkara PS; McCarthy JR; Tyms AS Antiviral Res; 1995 Aug; 27(4):325-34. PubMed ID: 8540753 [TBL] [Abstract][Full Text] [Related]
15. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner. Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941 [TBL] [Abstract][Full Text] [Related]
16. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus. Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018 [TBL] [Abstract][Full Text] [Related]
17. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624 [TBL] [Abstract][Full Text] [Related]